Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised controlled trial of intrathecal diamorphine in the treatment of chronic non-malignant pain
ISRCTN ISRCTN33733462
ClinicalTrials.gov identifier
Public title Randomised controlled trial of intrathecal diamorphine in the treatment of chronic non-malignant pain
Scientific title
Acronym N/A
Serial number at source N0557115188
Study hypothesis 1. Are intrathecal opioids useful in the treatment of severe chronic non-malignant pain?
2. Is therapeutic efficacy dose dependent?
3. Is gradual reduction of intrathecal opioid dose safe?
Lay summary Not provided at time of registration
Ethics approval Added 07/04/10: Birmingham and Black Country Ethics Committee, Dudley Local Research Ethics Committee 23/2/2002, ref REC/35/02/Jun
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Signs and Symptoms: Pain
Participants - inclusion criteria Added 07/04/10:
Intrathecal pump in situ patient at Russells Hall Hospital
Participants - exclusion criteria Added 07/04/10:
Patients failing to give consent


Anticipated start date 01/01/2003
Anticipated end date 31/12/2010
Status of trial Stopped
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Aim to recruit 24 patients to the study.
Interventions 1. Dose of diamorphine reduced every week by 20% of the preceding week's dose for 10 weeks
2. No change in dose of diamorphine for 10 weeks

Patient is blinded to the changes made by computer telemetry.

As of 04/10/2011 this trial has stopped due to an increasing number of patients leaving the study.
Primary outcome measure(s) 1. Analgesic consumption
2. Pain level measured using Visual Analogue Score (VAS)
3. Function measured by Oswestry Disability Score (ODS)
4. Psychological parameters measured by Hospital Anxiety & Depression Score (HAD) and 5. Pain Coping Strategies Questionnaire (PCSQ)
6. Sociological parameters measured by SF-36
7. Overall assessment of change measured by Global Impression of Change (GIC)
Secondary outcome measure(s) Not provided at time of registration
Sources of funding The Dudley Group of Hospitals NHS Trust (UK)
Trial website
Publications
Contact name Dr  Jonathan  Raphael
  Address Consultant in Pain Management
Guest Hospital
Tipton Road
  City/town Dudley
  Zip/Postcode DY1 4SE
  Country United Kingdom
  Tel +44 (0)1384 244809
  Fax +44 (0)1384 244808
  Email JH.Raphael@dgoh.nhs.uk
Sponsor Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)207 307 2622
  Fax +44 (0)207 307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 12/09/2003
Last edited 04/10/2011
Date ISRCTN assigned 12/09/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central